Literature DB >> 31889631

High Prevalence of EGFR Mutations in Lung Adenocarcinomas From Brazilian Patients Harboring the TP53 p.R337H Variant.

Malu Viter R Barbosa1, Vladmir C Cordeiro de Lima2, Maria Nirvana Formiga1, Cláudia A Andrade de Paula3, Giovana T Torrezan4, Dirce M Carraro5.   

Abstract

Entities:  

Keywords:  EGFR mutation; Hereditary cancer; Li-Fraumeni syndrome; Lung adenocarcinoma; p.R337H mutation

Mesh：

Substances：

Year:  2019        PMID： 31889631     DOI： 10.1016/j.cllc.2019.11.012

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  5 in total

1.  Mutational Portrait of Lung Adenocarcinoma in Brazilian Patients: Past, Present, and Future of Molecular Profiling in the Clinic.

Authors:  Helano C Freitas; Giovana Tardin Torrezan; Isabela Werneck da Cunha; Mariana Petaccia Macedo; Vanessa Karen de Sá; Marcelo Corassa; Elisa Napolitano E Ferreira; Augusto Obuti Saito; Graziela Zibetti Dal Molin; Vladmir C Cordeiro de Lima; Dirce Maria Carraro
Journal:  Front Oncol       Date:  2020-07-02       Impact factor: 6.244

2.  Prevalence of the Brazilian TP53 Founder c.1010G>A (p.Arg337His) in Lung Adenocarcinoma: Is Genotyping Warranted in All Brazilian Patients?

Authors:  Igor Araujo Vieira; Tiago Finger Andreis; Bruna Vieira Fernandes; Maria Isabel Achatz; Gabriel S Macedo; Daniel Schramek; Patricia Ashton-Prolla
Journal:  Front Genet       Date:  2021-02-02       Impact factor: 4.599

3.  Comprehensive genomic profiling of Brazilian non-small cell lung cancer patients (GBOT 0118/LACOG0418).

Authors:  Eldsamira Mascarenhas; Ana Caroline Gelatti; Luiz Henrique Araújo; Clarissa Baldotto; Clarissa Mathias; Mauro Zukin; Gustavo Werutsky; Patricia Pacheco; Rafaela Gomes; Gilberto de Castro; Vladmir Cláudio Cordeiro de Lima
Journal:  Thorac Cancer       Date:  2020-12-13       Impact factor: 3.500

4.  Case Report: A rare case of familial lung cancer requiring pneumonectomy in three male siblings.

Authors:  Andrey Kaprin; Oleg Pikin; Andrey Ryabov; Oleg Aleksandrov; Evgeniy Toneev; Ludmila Lubchenko; Ekaterina Zelenova
Journal:  Front Oncol       Date:  2022-08-02       Impact factor: 5.738

Review 5.  What 20 years of research has taught us about the TP53 p.R337H mutation.

Authors:  Emilia Modolo Pinto; Gerard P Zambetti
Journal:  Cancer       Date:  2020-08-17       Impact factor: 6.860
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.